Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of intravitreal triamcinolone acetonide (Kénacort Retard) versus dexamethasone implant (Ozurdex) for ocular disease
2015-000468-33Phase 3Completed
- Sponsor
- CHU de Nantes
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of triamcinolone acetonide and ozurdex in well-being (2 arms), sponsored by CHU de Nantes. Started Jul 2015; status: completed.
02
Drugs
triamcinolone acetonideozurdex
03
Conditions
well-being
Beyond the preview
Go deeper on 2015-000468-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000468-33.